PL327831A1 - Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms - Google Patents

Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms

Info

Publication number
PL327831A1
PL327831A1 PL97327831A PL32783197A PL327831A1 PL 327831 A1 PL327831 A1 PL 327831A1 PL 97327831 A PL97327831 A PL 97327831A PL 32783197 A PL32783197 A PL 32783197A PL 327831 A1 PL327831 A1 PL 327831A1
Authority
PL
Poland
Prior art keywords
diphenylchromanes
treating
production
application
menopause symptoms
Prior art date
Application number
PL97327831A
Inventor
Michael Shalmi
Niels Korsgaard
Birgitte Hjort Guldhammer
James Robertson Piggott
Virender Mohan Labroo
Steven Bain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL327831A1 publication Critical patent/PL327831A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
PL97327831A 1996-01-11 1997-01-09 Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms PL327831A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US983496P 1996-01-11 1996-01-11
US67826196A 1996-07-11 1996-07-11

Publications (1)

Publication Number Publication Date
PL327831A1 true PL327831A1 (en) 1999-01-04

Family

ID=26679921

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97327831A PL327831A1 (en) 1996-01-11 1997-01-09 Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms

Country Status (12)

Country Link
EP (1) EP0873120A1 (en)
JP (1) JP2000506505A (en)
KR (1) KR19990077156A (en)
AU (1) AU1367297A (en)
BR (1) BR9706967A (en)
CA (1) CA2241623A1 (en)
CZ (1) CZ217298A3 (en)
HU (1) HUP9902683A3 (en)
IL (1) IL124882A0 (en)
NO (1) NO983178L (en)
PL (1) PL327831A1 (en)
WO (1) WO1997025035A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
IL150463A0 (en) * 1999-12-30 2002-12-01 Signal Pharm Inc Compounds and methods for modulation of estrogen receptors
CA2581316C (en) 2004-09-21 2013-09-10 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US8835413B2 (en) 2004-10-20 2014-09-16 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
BRPI0818637A2 (en) 2007-10-16 2015-04-07 Repros Therapeutics Inc Methods of treating symptom of impaired fasting glucose, metabolic syndrome, metabolic syndrome, and impaired fasting glucose in subjects with secondary or idiopathic hypogonadotropic hypogonadism
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
EA026675B1 (en) 2010-06-16 2017-05-31 Эндорешерш, Инк. Methods of treating or preventing estrogen-dependent diseases
EP2635273B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
JP2015508825A (en) 2012-02-29 2015-03-23 レプロス セラピューティクス インコーポレイティド Combination therapy to treat androgen deficiency
MX368063B (en) 2014-02-07 2019-09-18 Novogen ltd Functionalised benzopyran compounds and use thereof.
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
CN116139125A (en) 2015-02-02 2023-05-23 梅制药公司 combination therapy
EP3373967B9 (en) 2015-11-10 2023-10-04 Paracrine Therapeutics AB Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
KR19990077156A (en) 1999-10-25
CZ217298A3 (en) 1999-01-13
WO1997025035A1 (en) 1997-07-17
NO983178L (en) 1998-07-10
CA2241623A1 (en) 1997-07-17
IL124882A0 (en) 1999-01-26
HUP9902683A3 (en) 2001-08-28
HUP9902683A2 (en) 2001-04-28
AU1367297A (en) 1997-08-01
BR9706967A (en) 1999-05-04
JP2000506505A (en) 2000-05-30
EP0873120A1 (en) 1998-10-28

Similar Documents

Publication Publication Date Title
PL327831A1 (en) Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms
PL330119A1 (en) Substituted 3,5-diphenyl-1,2,4-triazoles and their application as metals-chelating pharmaceutic agents
ZA942571B (en) 1,5 benzodiazepine derivatives
PL305701A1 (en) Pharmaceutical agent
NZ297342A (en) Thiadiazolidin-3-one 1,1-dioxides; medicaments
HU9502684D0 (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkane-carboxylic acid derivatives
EP0927038A4 (en) P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
AP9500731A0 (en) 1,5 benzodiazepine derivatives
AP9400657A0 (en) 1,5 benzodiazepine derivatives
ZA964373B (en) A pharmaceutical composition for treating lukemia
PL321585A1 (en) Personal washing agent inn the form of a bar
HRP980502B1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use as medicaments
SG65043A1 (en) Process for purifying crude 1,4-butanediol
ZA971716B (en) 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease
HU9400745D0 (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives
PL301653A1 (en) Pharmaceutical agent for preventing or treating arteriosclerosis
EP0661401A3 (en) Agent for treating textile materials.
AU5495398A (en) Idebenone containing combination agent for treating alzheimer's disease
KR19987002519A (en) Process for subsequent codensation of polycondensates , in particular of poyamide 6.6
CZ71095A3 (en) Track ballastway treating machine
PL317190A1 (en) Pharmaceutic composition for treating glaucoma
ZA93639B (en) New 4-cinnolinyl- and 4 naphthyridinyl-dihydropyridines, processes for their use in medicaments.
GB9323288D0 (en) Compatibilising agents
ZA9510694B (en) 1 3 4-oxadiazine derivatives
HU9402990D0 (en) Lock-system for safety locks